New! HIV & Hepatitis C Virtual Education Summits - May 16 & 17, 11A - 4P ET

Sanjeev Arora, MD, is director of Project ECHO (Extension for Community Healthcare Outcomes). He is also professor of medicine, director of the Office of Clinical Affairs, and executive vice chair for the Department of Internal Medicine at the University of New Mexico Health Sciences Center (UNMHSC). He has been involved in management of viral hepatitis for over 15 years, and he led the development and implementation of the Hepatitis C Disease Management Program at UNMHSC. Dr. Arora developed the Project ECHO model as a platform for service delivery, education, and evaluation.

Dr. Cohen is research director of Harvard Vanguard Medical Associates and Community Research Initiative of New England in Boston, Massachusetts. He is also a clinical instructor at Harvard Medical School. In addition, he works as an HIV clinical management consultant and internist at Harvard Pilgrim Health Care.

Joseph Eron, MD is a Professor of Medicine at the UNC Chapel Hill School of Medicine. In addition, he is also Adjunct Professor of Epidemiology, Gillings School of Global Public Health. Dr. Eron is the Director of Clinical Core, the UNC Center for AIDS Research and is also the Associate Director at the General Clinical Research Unit. Dr. Eron graduated from Harvard Medical School. His research interests are focused primarily on the study of HIV/AIDS.

Dr. Flamm received his MD degree from the University of Pennsylvania School of Medicine. He completed both a clinical fellowship in gastroenterology and a research fellowship in gastroenterology and hepatology at Beth Israel Hospital, Harvard Medical School. He then went on for further specialized training, completing a clinical fellowship in hepatology and liver transplantation at The Deaconess Hospital, Harvard Medical School. Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many other liver-related topics including viral hepatitis, autoimmune hepatitis, hepatic encephalopathy, and liver transplantation. He has an active clinical research program for patients with many different chronic liver diseases including chronic viral hepatitis (HBV and HCV).

Dr. Frank is the Director of the Clinical-Therapeutics Program of the Penn Center for AIDS Research, and he directs Penn’s clinical trial unit of the HIV Vaccine Trials Network. His main areas of research include: mechanisms underlying immune activation and immunopathogenesis of HIV infection, HIV vaccine and effectiveness of vaccination in HIV infected individuals, strategies for HIV prevention, and development of strategies to enhance update of HPV vaccination.

Khalil Ghanem, M.D., is board-certified in internal medicine and adult infectious diseases. His research interests include sexually transmitted infections, HIV/AIDS and the body's immune responses to such organisms. Ghanem offers clinical expertise in HIV/AIDS, sexually transmitted infections and bone/joint infections.

Dr. Gluck received his MD degree from New York Medical College and his JD degree from the British American University. He is currently serving as the Director of Critical Care Services and the Chief Academic Officer at the Swedish Covenant Hospital in Chicago, IL. Dr. Gluck also serves as Chairperson for the Ethics and Critical Care Committees at the Swedish Covenant Hospital and has contributed to over 50 Abstracts and Publications.

Debra A. Goff, PharmD, FCCP, is an Infectious Disease Specialist and director of the Infectious Diseases Residency program at The Ohio State University Medical Center (OSUMC) in Columbus, Ohio. Dr. Goff is a member of the Antimicrobial Stewardship Program (ASP). She is an Associate Professor at the College of Pharmacy. Dr. Goff received her bachelor of pharmacy degree, Doctor of Pharmacy degree, and performed her Pharmacy residency at the University of Illinois at Chicago. She has received numerous research grants and has lectured both nationally and internationally. She has published in several journals, including Clinical Infectious Diseases, Archives of Internal Medicine, Pharmacotherapy, Current Opinion in Infectious Diseases, and Journal of Infection. She is an active member of IDSA, ACCP, ASM, SIDP, and a board member of the National Foundation for Infectious Diseases.

Dr. Gorbach, Emeritus Director of the Nutrition/Infection Unit, is a Professor in the Departments of Medicine and Public Health and Community Medicine at Tufts University School of Medicine and a Professor in the Dorothy Friedman School of Nutrition Science and Policy at Tufts. Dr. Gorbach graduated from Tufts University School of Medicine in 1962, completed his residency in internal medicine at Cornell-Bellevue Medical Center, and then returned to Tufts Medical Center for a fellowship in infectious diseases. He received additional postgraduate training at the London School of Hygiene and Tropical Medicine and in gastroenterology at the Hammersmith Royal Postgraduate Medical School. Since 1969 Dr. Gorbach has been continuously funded as a principal investigator by the National Institutes of Health for research in infectious diseases and nutrition. Currently he is principal investigator on a program project grant, “Nutrition and HIV Infection,” an R01 award on “Nutrition Interventions in AIDS Wasting,” and an R01 award on “Nutritional Status in HIV - positive Hispanic Drug Abusers.” Dr. Gorbach has published over 490 papers and has authored 15 books.

Dr. Greenough, an international expert in infectious disease and a member of the Division of Geriatric Medicine at Johns Hopkins School of Medicine, has been a co-investigator on the Hospital at Home project since its inception. He has been an active member of the clinical investigation from the outset, participating in decisions on which diseases to treat, criteria for admission to the program, and methods to track clinical outcomes. During the pilot phase of Hospital at Home, Dr. Greenough joined Drs. Leff and Burton in providing in-the-home care for patients admitted to the program. Dr. Greenough is a member of the Division of Geriatric Medicine responsible for the Ventilator Rehabilitation Unit of the Johns Hopkins Bayview Care Center, as well as subacute and long-term care. He consults on serious and complex wounds with the Wound Care Team of this facility and has a background in infectious diseases and fluid and electrolyte management. His research interests focuses on oral rehydration therapy, malnutrition, and wound care in the elderly.

A professor in the Division of Pediatric Infectious Diseases, as well as Professor, International Health (Disease Prevention and Control) at Johns Hopkins Bloomberg School of Public Health, Dr. Halsey's primary research and teaching effort is directed toward the prevention of infectious diseases with the safest vaccines possible. Dr. Halsey has conducted or participated in epidemiological studies of vaccine-preventable diseases and phase I, II and III vaccine trials of hepatitis B, hepatitis A, inactivated polio virus, pertussis, Haemophilus influenzae type B, tetanus, Lyme disease, rotavirus, Argentina Hemorrhagic Fever, and influenzae vaccine viruses. The control of measles has been a particular focus of interest and he supports the ongoing measles and poliomyelitis eradication efforts. His interest in vaccine safety stems from experience with vaccine-associated paralytic poliomyelitis, increased mortality after high titer measles vaccines, and smallpox vaccine.

Dr. Hook is a Professor of Medicine and Epidemiology at the University of Alabama, Birmingham, and Director of the STD Control Program for the Jefferson County (Alabama) Department of Health. Dr. Hook’s laboratory has emphasized diagnostic testing for Neisseria gonorrhoeae, Chlamydia trachomatis and syphilis, providing a platform for a wide variety of studies. His laboratory is one of 5 CDC-funded reference laboratories for the Gonococcal Isolate Surveillance Project which has monitored trends in gonococcal epidemiology and antimicrobial resistance in the U.S. since 1988. In addition, data generated by his laboratories have reflected collaboration with other faculty of the Infectious Diseases Division and other Departments within the School of Medicine (Obstetrics and Gynecology, Pediatrics and Microbiology) and other UAB Schools (Public Health, Social and Behavioral Sciences).

Dr. Charles Howell received his medical degree from Howard University. He completed his residency at Baylor College of Medicine and completed his fellowship at the University of Colorado Health Sciences Center in gastroenterology. Dr. Howell’s clinical interests include management of chronic liver diseases, particularly hepatitis B and C, primary biliary cirrhosis and autoimmune hepatitis.

Dr. Ayman Koteish is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Dr. Koteish completed his residencies at the Good Samaritan Hospital of Maryland and the American University of Beirut. He completed his fellowship at the Johns Hopkins Hospital.

Dr. Dan Kuritzkes is a professor of medicine at Brigham & Women's Hospital, Infectious Disease/Partners AIDS Research Center, and an infectious diseases professor at Harvard Medical School. He is also principal investigator and chair of the AIDS Clinical Trials Group (ACTG) and associate editor for Journal of Infectious Diseases. His research interest focuses on antiretroviral therapy and drug resistance. Dr. Kuritzkes was chair, Clinical Sciences Study Section Review Panel, University of California, University-Wide AIDS Research Program. Dr. Kuritzkes has authored more than 48 journal articles on HIV-related topics. He received his B.S. and M.S. in molecular biophysics and biochemistry from Yale and went on to receive his M.D. from Harvard Medical School.

Dr. Andrew Muir attended medical school at Duke University in Durham, North Carolina. He completed his residency in the Department of Medicine, where he served as chief resident. Dr. Muir also completed fellowships in gastroenterology and health services research at Duke and at the Durham Veterans Administration Medical Center, respectively. Dr. Muir joined the faculty in the Division of Gastroenterology at Duke in 2000. In 2001, he completed a Master of Health Sciences degree at Duke. His research activities are focused on developing innovative treatments for a variety of liver diseases. Dr. Muir helped to create the site-based research program in gastroenterology at the Duke Clinical Research Institute (DCRI), a program he now leads.

Trish M. Perl, MD, MSc, is in the Department of Epidemiology at the Bloomberg School of Hygiene at Johns Hopkins University. Dr. Perl is also Director of Hospital Epidemiology and Infection Control, and the Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Perl received her Bachelor of Arts and medical degree from the University of North Carolina at Chapel Hill and a Master of Science degree from McGill University in Montreal, Canada. She currently serves on the editorial board of the American Journal of Infection Control and is a reviewer for Infection Control and Hospital Epidemiology, JAMA, and the New England Journal of Medicine. Her scientific interests encompass Avian Flu, Clostridium difficile, surgical site infections, emerging infection prevention and interventions to prevent healthcare associated infections, bioterrorism preparedness, and patient and healthcare worker safety.

Dr. Reddy is a Professor of Medicine at the Hospital of the University of Pennsylvania. In addition, he is also the Director of Hepatology, HUP, Hospital of the University of Pennsylvania and Medical Director of Liver Transplantation, HUP, Hospital of the University of Pennsylvania.

Dr. Schreckenberger is a professor of pathology at a school of medicine and director of the clinical microbiology laboratory and associate director of molecular pathology at a university medical center, both in Chicago, Illinois. He is a diplomate of the American Board of Medical Microbiology and a fellow in the American Academy of Microbiology. Dr. Schreckenberger’s research interests include identification and characterization of enteric and nonfermenting Gram-negative bacilli, rapid and automated identification of bacteria, methods for detection of antimicrobial resistance, and lowering laboratory costs by controlling utilization.

Dr. Soreng received her BS in Biology from the University of Washington in Seattle. While completing her studies, she conducted clinical research on herpes viruses. She was awarded a Ph.D. in Immunology and Molecular Pathogenesis from Emory University in Atlanta, GA, publishing a thesis on protein synthesis and cytoskeletal elements in the Class II restricted processing of antigen. She submitted and won a grant from the ASM for a two-year post-doctoral appointment at the CDC for the investigation of the simian homologue of CD46 and its potential role as a measles virus receptor and mediator of pathogenesis. Dr. Soreng currently heads the Clinical and Scientific Marketing team at Siemens Healthcare Diagnostics. She both writes and manages the production of scientific and educational literature, including peer-reviewed publications, White papers, and other educational collateral such as PowerPoint’s on clinical diagnostics and disease state management. She frequently lectures on topics in infectious disease, including HIV, Hepatitis, and emerging markers in Sepsis and Liver Disease among other subjects.

Dr. Rohit Talwani graduated medical school from the University of South Carolina. He completed his internship in internal medicine at Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois and his residency at Palmetto Richland Memorial Hospital at University of South Carolina School of Medicine. Dr. Talwani completed his fellowship in infectious disease at Rush-Presbyterian-St.Luke’s Medical Center in Chicago, IL. His research interests include viral hepatitis and his clinical specialty include infectious diseases.

Dr. Pablo Tebas directs the adult AIDS Clinical Trials Unit (ACTU) of the University of Pennsylvania. His main research interests are the treatment of HIV infection and the study of the metabolic complications associated with HIV infection and its treatment. He completed medical school at the Universidad Autonoma in Madrid, Spain and his infectious disease training at the Washington University in Saint Louis, Missouri. He is also an Associate Professor of Medicine.

David L. Thomas, M.D., M.P.H., is Professor of Medicine and Epidemiology at the Johns Hopkins Schools of Medicine and Public Health, and Chief of the Division of Infectious Diseases at the Johns Hopkins School of Medicine. He joined Johns Hopkins in 1993. Dr. Thomas is trained in internal medicine and infectious diseases and cares for patients with chronic viral hepatitis. He also oversees clinical research projects whose aims are focused on understanding the natural history and pathogenesis of hepatitis C virus infection.

David Alain Wohl, M.D., is an associate professor of medicine in the Division of Infectious Diseases at the University of North Carolina (UNC). He is site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill and codirects HIV services for the North Carolina Department of Correction. In 2011, Dr. Wohl also became director of the North Carolina AIDS Education and Training Center. Dr. Wohl's research interests fall into two major areas: the metabolic complications of HIV and its therapies, and the nexus between incarceration and the HIV epidemic.

Jonathan M. Zenilman is Professor in Infectious Diseases Division at Johns Hopkins University School of Medicine, and Chief of the Infectious Diseases Division at Johns Hopkins Bayview Medical Center. He is an international authority on the clinical epidemiology and management of sexually transmitted diseases and HIV prevention, infectious disease surveillance, and has served on U.S. government, international, and non-profit advisory committees, including the National Institutes of Health and the Institute of Medicine. Besides clinical care, Dr Zenilman is the Director of the Johns Hopkins Center for STD Research and Prevention, He also manages a large extramurally funded research program, teaches at the Johns Hopkins School of Public Health, mentors the research of Ph.D and postdoctoral students, and has authored over 200 publications.